Sucralfate and Everolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Everolimus (everolimus). Common drug interactions include nausea among females and hyperkalaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Everolimus. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

On Jul, 13, 2026

17 people who take Sucralfate and Everolimus together, and have interactions are studied.

Sucralfate and Everolimus drug interactions.

What are the common drug interactions of Sucralfate and Everolimus, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Decreased appetite
Fatigue (feeling of tiredness)
Vomiting
Weight decreased
Asthenia (weakness)
Diarrhoea
Hypotension (abnormally low blood pressure)
Neutropenia (an abnormally low number of neutrophils)
Stomatitis (inflammation of mucous membrane of mouth)

male:

Hyperkalaemia (damage to or disease of the kidney)
Renal impairment (severely reduced kidney function)
Procedural pain
Renal transplant
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Urinary tract infection
Agitation (state of anxiety or nervous excitement)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bladder spasm
Death

What are the common drug interactions of Sucralfate and Everolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Neutropenia (an abnormally low number of neutrophils)
Hirsutism (abnormal growth of hair on a person's face and body, esp. on a woman)

40-49:

n/a

50-59:

Decreased appetite
Diarrhoea
Nausea (feeling of having an urge to vomit)
Stomatitis (inflammation of mucous membrane of mouth)
Abdominal pain upper
Acute hepatic failure
Blood lactate dehydrogenase increased
Cough
Encephalopathy (functioning of the brain is affected by some agent or condition)
Exercise tolerance decreased

60+:

Nausea (feeling of having an urge to vomit)
Vomiting
Anaemia (lack of blood)
Anxiety
Back pain
Blood glucose increased
Blood pressure diastolic decreased
Blood pressure systolic increased
Carcinoid tumour (slow growing tumour)
Decreased appetite

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 5 people, 29.41%
Hepatitis B: 2 people, 11.76%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 11.76%
Breast Cancer Female: 2 people, 11.76%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 1 person, 5.88%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 5.88%
Pancreatic Neuroendocrine Tumor: 1 person, 5.88%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.88%
Diarrhea: 1 person, 5.88%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Everolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously